Mark Sorial

6PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumoursChemotherapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 23, 2026
Correlation between lymphocyte counts and PD-L1 immune-related adverse events.

Zachary Sawyer, Mark Sorial, Justin C Liauw

|Dec 05, 2025
Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.

Mark N Sorial, Luis E Malpica Castillo, Carlos Chiattone

|Jun 17, 2025
Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas.

Josie G Ford, Min Jung Koh, Alexandra W Lenart

|May 01, 2025
Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study.

Mark N Sorial, Jessy Xinyi Han, Min Jung Koh

|Oct 31, 2024
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.

Jessy Xinyi Han, Min Jung Koh, Leora Boussi

|Nov 22, 2019
Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation.

Mark N Sorial, Rebecca A Greene, Andrew R Zullo

Pageof 1

Frequent Collaborators

4 joint publications

Salvia Jain

3 joint publications

Robert Stuver

3 joint publications

Henry Miles Prince

3 joint publications

Pier Luigi Zinzani